ArticleFrontiers in immunology2023

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy.

Dirk Westhölter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.